Explore
Advances in Diagnosis and Therapy of Neuroendocrine Neoplasms
Eva Segelov (editor)
2021
0 Ungluers have
Faved this Work
Login to Fave
This Special Issue is dedicated to neuroendocrine neoplasms (NENs), a category of malignancy that demonstrates wide clinical heterogeneity, posing major challenges in diagnosis and management. There have been significant advances in the field of NEN genomics, pathology, imaging, and treatment over the past five years. NENs are examples of rare tumours (although their incidence and prevalence are increasing) where international collaborative efforts have allowed the generation of high-level evidence to guide optimal patient-centred care. This issue presents both reviews and original papers to provide comprehensive state-of-the-art understanding of this fascinating disease.
This book is included in DOAB.
Why read this book? Have your say.
You must be logged in to comment.
Rights Information
Are you the author or publisher of this work? If so, you can claim it as yours by registering as an Unglue.it rights holder.Downloads
This work has been downloaded 138 times via unglue.it ebook links.
- 50 - pdf (CC BY) at Unglue.it.
- 88 - pdf (CC BY) at res.mdpi.com.
Keywords
- 2017 WHO classification
- 2019 WHO classification
- body mass index
- cancer care
- cancer-driven genes
- carcinoid heart disease
- carcinoid syndrome
- chemotherapy
- CommNETs
- curative surgery
- Diabetes Mellitus
- follow-up
- germline mutations
- grading
- guidelines
- liver metastases
- long-term functional outcomes
- malignant castration-resistant prostatic cells
- Management
- MANEC
- medicine
- medullary thyroid carcinoma
- Meta-analysis
- metastases
- metronomic treatment
- midgut
- MiNENs
- mixed adeno-neuroendocrine carcinoma
- mixed non-neuroendocrine neuroendocrine neoplasms
- modified Delphi
- multidisciplinary
- mutational mechanism
- NETs
- neuroendocrine neoplasms
- neuroendocrine tumor
- neuroendocrine tumors
- neuroendocrine tumour
- neuroendocrine tumours
- Notch
- outcome
- pancreatectomy
- pancreatic exocrine insufficiency
- pancreatic NET
- pancreatic neuroendocrine neoplasms
- pancreatic neuroendocrine tumours
- parenchyma-sparing surgery
- QPIs
- quality performance indicators
- recurrence
- relapse
- resection
- risk factor
- second-line
- small bowel NET
- small bowel neuroendocrine tumours
- small cell lung carcinoma
- somatostatin analogues
- Staging
- temozolomide
Links
DOI: 10.3390/books978-3-03943-746-7Editions